Core Viewpoint - Dazhenglin Pharmaceutical Group Co., Ltd. will begin paying interest on its convertible bonds on October 22, 2025, for the period from October 22, 2024, to October 21, 2025 [2][13]. Summary by Sections Bond Issuance Details - The convertible bonds, named "Dazheng Convertible Bonds," were issued on October 22, 2020, with a total issuance amount of RMB 1,405 million [4]. - The bonds have a term of 6 years, maturing on October 21, 2026 [2][4]. - The face value of each bond is RMB 100 [2]. Interest Rate and Payment - The interest rates for the bonds are structured as follows: 0.30% for the first year, 0.60% for the second year, 1.00% for the third year, 1.50% for the fourth year, 1.80% for the fifth year, and 2.00% for the sixth year [2]. - For the fifth year, the interest rate is set at 1.80%, resulting in an interest payment of RMB 1.80 per bond (before tax) [13][17]. Payment Schedule - The bondholders will be registered on October 21, 2025, with the interest payment date also set for October 22, 2025 [4][19]. - The interest will be paid annually, and if the payment date falls on a holiday, it will be postponed to the next working day [6]. Conversion Terms - The conversion period for the bonds is from April 28, 2021, to October 21, 2026 [8]. - The initial conversion price is RMB 83.85 per share, while the latest conversion price is RMB 17.69 per share [10]. Tax Implications - Individual investors are subject to a 20% tax on interest income, resulting in a net payment of RMB 1.44 per bond after tax [17]. - Non-resident enterprises are exempt from corporate income tax on interest income until December 31, 2025 [18]. Credit Rating - The company and its convertible bonds have been rated "AA" with a stable outlook by China Chengxin International Credit Rating Co., Ltd. [10][11].

Core Points - The company has received approval from the China Securities Regulatory Commission (CSRC) for the registration of a specific stock issuance [1][2] - The issuance must be conducted strictly according to the submitted documents and issuance plan to the Shanghai Stock Exchange [2] - The approval is valid for 12 months from the date of registration [3] Regulatory Compliance - The company is required to report any significant events to the Shanghai Stock Exchange from the date of registration until the completion of the issuance [3] - The board of directors will handle the issuance matters within the stipulated timeframe and fulfill information disclosure obligations [3] Contact Information - The company and its sponsor have provided contact details for further inquiries regarding the stock issuance [4]

Fundraising Overview - The company has been approved to issue 40 million shares at a price of 93.50 CNY per share, raising a total of 3.74 billion CNY, with a net amount of approximately 3.53 billion CNY after deducting issuance costs [2] - The company has received 522.58 million CNY in excess funds from the fundraising [2] Fund Management - The company has established a fundraising management system to ensure the proper use of raised funds, including a dedicated account for fund storage and management [3] - The company has signed a tripartite supervision agreement with its sponsor and several banks for the management of the fundraising account [3] Fund Usage and Project Updates - The company has approved the establishment of a wholly-owned subsidiary in South Korea for an automotive electronics factory project, utilizing part of the excess funds for this investment [4] - The company has also approved additional investments in the Harbin Global Automotive Electronics R&D Center [4] Account Closure - The company has completed the closure of its fundraising special accounts due to the full utilization of the funds [5] Cash Management - The company has been authorized to use up to 2.8 billion CNY of idle fundraising and 2 billion CNY of idle self-owned funds for cash management, focusing on safe and liquid financial products [7] - The company has redeemed a total of 1.644 billion CNY from various fixed-term deposits, generating a profit of 3.71 million CNY [8] - As of the announcement date, the company has 700 million CNY of idle funds still under cash management, with no overdue amounts [9][10]

Group 1 - The fund manager, Guotai Fund Management Co., Ltd., announced the resumption of subscription services for the fund starting from October 15, 2025, after a suspension on July 28, 2025 [2][4]. - The fund has set a limit on the subscription and regular investment amount to a maximum of 10,000.00 yuan per day for each fund account, with any excess subject to partial or complete rejection [4][5]. - The fund's third closed period is from October 15, 2024, to October 14, 2025, and the next open period for subscription, redemption, and conversion will be from October 15, 2025, to November 11, 2025 [7][10]. Group 2 - The Guotai Fund Management Co., Ltd. has launched the Guotai SSE Sci-Tech Innovation Board Artificial Intelligence ETF, which began trading on the Shanghai Stock Exchange on October 15, 2025 [33]. - As of October 14, 2025, the fund's investment in the underlying index components and alternative components accounted for 97.85% of the fund's net asset value, complying with relevant regulations and the fund contract [33].

Core Viewpoint - China Galaxy Securities has received approval from the China Securities Regulatory Commission (CSRC) to issue short-term corporate bonds with a total face value of up to 15 billion yuan [1]. Group 1: Company Actions - On October 14, China Galaxy announced the approval for the issuance of short-term corporate bonds, which can be issued in tranches within a 24-month validity period [1]. - The stock price of China Galaxy rose by 0.34% to 17.80 yuan per share on October 14, with a year-to-date increase of 18.23% [4]. Group 2: Industry Trends - In 2023, securities firms have been actively issuing bonds, with several firms recently obtaining bond issuance quotas. For instance, Industrial Securities received approval for up to 20 billion yuan in corporate bonds, while Zhongyuan Securities was approved for 1.2 billion yuan in subordinated bonds [6]. - As of October 14, 2023, the total number of bonds issued by securities firms in China reached 708, with a total issuance scale of 1.29 trillion yuan, marking a year-on-year increase of 70.23% [7]. - The increase in financing demand among securities firms is attributed to a significant recovery in the equity market and active trading, alongside a low interest rate environment that makes bond financing more attractive [8].

Group 1 - China Galaxy Securities has received approval from the China Securities Regulatory Commission (CSRC) to issue short-term corporate bonds with a total face value not exceeding 15 billion yuan [2] - The approval is valid for 24 months from the date of registration, allowing for phased issuance of the bonds within this period [2] - The stock price of China Galaxy increased by 0.34% to 17.80 yuan per share, with a year-to-date increase of 18.23% [4] Group 2 - The bond issuance activity among securities firms has been robust this year, with several firms receiving new bond issuance quotas [6] - As of October 14, 2023, the total number of bonds issued by securities firms in China reached 708, with a total issuance scale of 1.29 trillion yuan, representing a year-on-year increase of 70.23% [6] - Major firms like Huatai Securities and China Galaxy have issued over 100 billion yuan in bonds, with respective issuance scales of 110.4 billion yuan and 107.9 billion yuan [6] Group 3 - The recovery of the equity market and active trading have significantly boosted the demand for financing among securities firms [7] - The low interest rate environment has made bond financing more attractive, encouraging firms to opt for debt issuance [7]

Core Viewpoint - China Galaxy Securities has received approval from the China Securities Regulatory Commission (CSRC) to issue short-term corporate bonds with a total face value of up to 15 billion yuan [1] Group 1: Company Actions - China Galaxy announced the approval for the issuance of short-term corporate bonds, which can be issued in tranches within a validity period of 24 months from the date of approval [1] - The stock price of China Galaxy increased by 0.34% to 17.80 yuan per share, with a year-to-date increase of 18.23% [3] Group 2: Industry Trends - The bond issuance activity among securities firms has been robust this year, with several firms receiving bond issuance quotas [5] - As of October 14, 2023, the total number of bonds issued by securities firms in China reached 708, with a total issuance scale of 1.29 trillion yuan, representing a year-on-year increase of 70.23% [5] - Major firms like Huatai Securities and China Galaxy have issued bonds exceeding 100 billion yuan, with respective issuance scales of 110.4 billion yuan and 107.9 billion yuan [5] - The current low-interest-rate environment has encouraged securities firms to opt for bond financing due to lower costs [6]

新华财经北京10月14日电（王菁）随着第二批科创债ETF集体上市，银行理财资金正以前所未有的热情 涌入这一创新债券品类，在实现收益与流动性平衡的同时，也为金融市场支持科技创新开辟了新路径。 今年以来，债券市场迎来一股新生力量——科创债ETF。近三个月的时间，全市场科创债ETF产品已迅 速增至24只，总规模突破2500亿元大关。 业内人士表示，这一规模扩张背后，理财资金成为最主要的推动力。数据显示，银行系理财机构已在多 只科创债ETF中占据重要席位，在某些产品中甚至合计持有近八成的份额。 理财资金率先担当主力科创债ETF迅速成为市场新宠 科创债ETF市场正在经历爆发式增长。从7月首批10只产品募集289.88亿元，到9月第二批14只产品募集 规模扩大至407.86亿元，截至10月13日，科创债ETF上市交易规模在短时间内完成了从零到2523.04亿元 的跨越。 具体来看，当前16只科创债ETF规模已突破百亿元，其中嘉实科创债ETF以210.79亿元的规模领跑，鹏 华、招商等公司的产品紧随其后，规模均超过180亿元。 在这轮扩容浪潮中，银行理财资金的配置需求成为主要推手。从持有人结构看，兴业中证AAA科创债 ET ...

Core Points - The announcement from Leike Defense indicates that CITIC Construction Investment Securities has been appointed as the independent financial advisor for the company's issuance of shares, convertible bonds, and cash payment for asset acquisition, along with raising supporting funds [2] - The transaction has been completed, and the continuous supervision period ended on December 31, 2021, but the convertible bonds issued are still within their validity period, necessitating ongoing advisory duties from CITIC Construction Investment Securities [2] - A change in the financial advisor has occurred, with Wang Zhiyu stepping down due to personal work adjustments, and Wang Yuming has been appointed to continue the advisory role [2]

证券日报网讯 10月14日晚间，沪光股份发布公告称，公司近日收到中信建投证券股份有限公司（简 称"中信建投"）《关于更换昆山沪光汽车电器股份有限公司2022年非公开发行股票持续督导保荐代表人 的函》，原2022年非公开发行股票项目的持续督导保荐代表人孙林先生因工作变动，无法继续履行保荐 代表人职责。为切实做好持续督导工作，中信建投指派保荐代表人陈启强先生接替孙林先生继续担任公 司2022年非公开发行股票项目的持续督导保荐代表人，继续履行持续督导职责。 （文章来源：证券日报） ...